Veradigm (NASDAQ:MDRX) Shares Up 4.9% – Still a Buy?

Veradigm Inc. (NASDAQ:MDRXGet Free Report) was up 4.9% during trading on Monday . The stock traded as high as $5.70 and last traded at $5.35. Approximately 18,873 shares were traded during trading, a decline of 97% from the average daily volume of 655,681 shares. The stock had previously closed at $5.10.

Analyst Ratings Changes

Several research analysts have weighed in on MDRX shares. Stephens increased their price target on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Friday, January 31st. StockNews.com began coverage on Veradigm in a research report on Friday. They set a “hold” rating on the stock.

Get Our Latest Analysis on MDRX

Veradigm Stock Performance

The business’s 50 day moving average is $7.86 and its two-hundred day moving average is $9.12.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.